20/02/2026 09:16

Sonic Healthcare (SHL) $23.34

Sonic Healthcare (SHL) +9.89%: a reassuring result yesterday for the medical diagnostics business after a tough few years,  with revenue ahead of consensus and guidance maintained, while management continues to address US margin pressure that has plagued operations since the Covid bump.

Read more

16/10/2025 09:32

Sonic Healthcare Ltd (SHL) $21.21

This global medical diagnostics company has struggled for almost four years. We discussed it at length in August Here, adopting a neutral stance and removing it from our Growth Portfolio Hitlist when it was trading ~$24.

Read more

27/08/2025 09:47

Sonic Healthcare Ltd (SHL) $23.84

This Sydney-based global medical diagnostics company operates one of the world’s largest networks of pathology labs, imaging/radiology services, and primary care clinics across Australia, the US, and Europe.

Read more

07/05/2025 09:20

Sonic Healthcare Ltd (SHL) $26.14

Read more

19/11/2024 17:04

Sonic Healthcare Ltd (SHL) $27.99

SHL was the second-best-performing stock into the close, finishing the session up ~7%. Today's well-received AGM saw the board cite growth in its base business and its expanding global footprint across seven countries.

Read more

11/07/2024 09:18

Sonic Healthcare Ltd (SHL) $25.83

We touched on SHL last month after an FY24 earnings guidance miss sent the stock below $24. As we said at the time, to press the buy button on SHL, we need to believe that substantial operating performance improvement can be delivered in FY25 and not pushed into FY26 / beyond. At this stage, we are comfortable being an observer as the stock isn't cheap enough to take on the risks of further operational disappointment.

Read more

27/06/2024 09:56

Sonic Healthcare Ltd (SHL) $26.25

SHL’s FY24 earnings guidance led to downgrades of around 8%, which initially saw the stock spike under $24. However, it has recovered strongly, trading close to levels before the result. Cost pressures have been the issue for SHL, with too many collection sites and staff costs the main issue, though we see these improving over the coming 12 months.

Read more

21/05/2024 16:42

Sonic Healthcare (SHL) $25.01

SHL –6.01%: Sold off today although the worst of it was seen early with the shares recovering from their morning lows following a downgrade to guidance. Organic sales guidance is for 6% growth for the full year (no prior guidance had been provided) which is broadly inline with current consensus

Read more

28/03/2024 09:43

Sonic Healthcare Ltd (SHL) $29.28

Diagnostics business SHL has struggled over recent years, but they showed some signs of improvement at their result in February. This is a solid business, but COVID was ultimately not kind to them. While it delivered a big short term sugar hit to revenue, SHL’s cost base also blew out which they have carried into a weaker sales environment i.e. they haven't pivoted quick enough.

Read more

17/02/2023 09:20

Sonic Healthcare Ltd (SHL) $33.20

Diagnostics company SHL rallied +15.1% yesterday after beating market expectations, they delivered a profit that was 50% higher than before COVID – revenue over the last few years was elevated due to massive PCR testing, hopefully, a thing of the past.

Read more